Kurz, Annemarie, Farlow, M and Lefevre, Gilbert (2009) Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review. International journal of clinical practice, 63 (5). pp. 799-805. ISSN 1742-1241

Abstract

Cholinesterase inhibitors have all been available in oral formulations, but a rivastigmine transdermal patch has now been developed and is approved in many countries worldwide for the treatment of mild-to-moderate Alzheimer's disease (AD) (including the USA, Latin America, Europe and Asia).

Item Type:	Article
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez...
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez...
Date Deposited:	28 Jan 2012 00:45
Last Modified:	01 Feb 2013 00:47
URI:	https://oak.novartis.com/id/eprint/5093